Prostate Adenocarcinoma — Trials

Prostate Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

433 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 133
Recruiting: 62
Ph III recruiting: 5
Growth YoY: —
Industry share: 5%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 31.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (71)

clinicaltrialsPublishedShowing 51–56 of 56 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00879619	Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients	terminated	Phase 1 / Phase 2	4	John P. FruehaufOTHER	1	Feb 1, 2017	clinicaltrials
NCT02024685	Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial	terminated	N/A	76	Case Comprehensive Cancer CenterOTHER	1	Nov 10, 2015	clinicaltrials